| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.28 | 9e-06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.2 |